financetom
Business
financetom
/
Business
/
Cooper Standard Q3 sales miss estimates, posts surprise adjusted loss
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Cooper Standard Q3 sales miss estimates, posts surprise adjusted loss
Oct 30, 2025 2:23 PM

Overview

* Cooper Standard ( CPS ) Q3 sales rose 1.5% yr/yr but missed analyst expectations

* Adjusted net loss improved yr/yr but missed analyst estimates

* Adjusted EBITDA increased yr/yr but missed analyst expectations

Outlook

* Cooper Standard ( CPS ) revises full-year sales guidance to $2.68 bln - $2.72 bln

* Company expects 2025 adjusted EBITDA of $200 mln - $210 mln

* Company cites strong demand for light vehicle production despite disruptions

Result Drivers

* SALES GROWTH DRIVERS - Sales increased 1.5% due to favorable foreign exchange and volume mix, partially offset by customer price adjustments

* EFFICIENCY IMPROVEMENTS - Improved adjusted net loss driven by increased manufacturing and purchasing efficiency and favorable foreign exchange

* CASH FLOW INCREASE - Operating cash flow increased by $10.8 mln due to improved operating earnings and positive net change in working capital

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q3 Sales Miss $695.5 $705.23

mln mln (3

Analysts

)

Q3 Miss -$4.4 $3.9 mln

Adjusted mln (2

Net Analysts

Income )

Q3 Net -$7.6

Income mln

Q3 Miss $53.3 $60.46

Adjusted mln mln (3

EBITDA Analysts

)

Q3 Gross $87.1

Profit mln

Analyst Coverage

* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy", 1 "hold" and no "sell" or "strong sell"

* The average consensus recommendation for the auto, truck & motorcycle parts peer group is "buy"

* Wall Street's median 12-month price target for Cooper-Standard Holdings Inc ( CPS ) is $37.00, about 4.2% below its October 29 closing price of $38.56

Press Release:

For questions concerning the data in this report, contact [email protected]. For any other questions or feedback, contact .

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Cushman & Wakefield Completes Redomiciliation to Bermuda From England and Wales
Cushman & Wakefield Completes Redomiciliation to Bermuda From England and Wales
Mar 10, 2026
08:32 AM EST, 11/28/2025 (MT Newswires) -- Cushman & Wakefield ( CWK ) said Friday that the change of its place of incorporation to Bermuda from England and Wales has been completed. Shares of the new entity will trade on the New York Stock Exchange from today with the same CWK symbol. ...
Form 8.3
Form 8.3
Mar 10, 2026
LONDON--(BUSINESS WIRE)--   FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: NATIXIS SA (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle...
ASP Isotopes Extends Deadline to Meet Closing Conditions for Renergen Acquisition
ASP Isotopes Extends Deadline to Meet Closing Conditions for Renergen Acquisition
Mar 10, 2026
09:14 AM EST, 11/28/2025 (MT Newswires) -- ASP Isotopes ( ASPI ) said in a regulatory filing Friday that it and Renergen have agreed to extend the date for completing its acquisition of the South African company to Jan. 30. The date, originally Sept. 30, had been postponed to Nov. 28, the company said. A further extension will give the...
Profound Medical Launches AI-Powered Module to Treat Benign Prostatic Hyperplasia
Profound Medical Launches AI-Powered Module to Treat Benign Prostatic Hyperplasia
Mar 10, 2026
08:35 AM EST, 11/28/2025 (MT Newswires) -- Profound Medical ( PROF ) said Friday it is launching its Tulsa-AI Volume Reduction module to treat patients with benign prostatic hyperplasia (BPH), or enlarged prostate, at the Radiological Society of North America meeting in Chicago next week. BPH, a non-cancerous enlargement of the prostate gland due to an overgrowth of prostate cells,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved